Skip to main content

Table 1 Age, sex distribution, outcome, comorbidities, symptoms, and chest X-ray of the studied group

From: Endocrine, metabolic, and hepatic dysfunction in patients with COVID-19 pneumonia with severe and critically ill status

Age

Mean ± SD

59.98 ± 12.88

 Median

61.5

 Range

35.00–107.00

Sex

No

%

 Male

42

56

 Female

33

44

Outcome

No

%

 Deteriorated

52

69.3

 Improved

23

30.6

Comorbidities

No

%

 Asthma

4

5.3

 Chronic kidney disease (CKD)

12

16

 Diabetes mellitus (DM)

30

40

 Hypertension (HTN)

26

34.7

 Hypothyroidism

2

2.7

 Ischemic heart disease (IHD)

12

16

 None

21

28

Symptoms

No

%

SOB

 Deteriorated

52

69.3

 Improved

23

30.6

Cough

  

 Deteriorated

52

69.3

 Improved

23

30.6

Chest X-ray after admission

No

%

 Deteriorated

52

69.3

 Improved

23

30.6

Length of hospitalization

 Patients with comorbidities

35.65 days

 

 Patients without comorbidities

22.32 days

 
  1. SD = standard deviation